XIANNUOXIN:Simnotrelvir Tablets/Ritonavir Tablets (co-packaged)

XIANNUOXIN:Simnotrelvir Tablets/Ritonavir Tablets (co-packaged)

Indications:

Indications:


It is used for the treatment of adult patients with mild to moderate COVID-19 infections.


XIANNUOXIN is the first 3CL-targeting anti-COVID-19 innovative drug with independent intellectual property rights in China, which inhibits the 3CL protease necessary for SARS-CoV-2 viral replication, making the virus lose its ability to infect normal cells and spread. 


It is effective for all known COVID-19 mutants, with good overall safety.